GL1X · GenesisL1 explorer

Research workbench

Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI19

Analyse Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI19 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7UUC
Type
protein
Length
301 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.6
Source
Severe acute respiratory syndrome coronavirus 2
Molecule
3C-like proteinase nsp5
EC
3.4.22.69
UniProt
P0DTD1
Ligands
81L
Pockets
2 · best druggability 0.42

Structure

x-ray diffraction · resolution 1.6 · 1 distinct chain · 25% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase nsp5 (EC 3.4.22.69)protein30125% helix, 29% strandP0DTD1

Ligands and binding sites

  • 81L · N-[(benzyloxy)carbonyl]-3-methyl-L-valyl-3-cyclopropyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-alaninamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11470.420.7527empty
21230.380.742781L

Modifications

Observed in the structure: 4 modified, 1 covalent (oxidation, covalent ligand).

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.